factual
LNP delivery limited to arm and liver
Lipid nanoparticles currently reach only two places well: immune cells at the injection site in the arm, and the liver, because everything injected is filtered through the liver; delivery to pancreas, brain, heart, and kidney remains an unsolved tropism problem.
factualpending
Speaker
Jeff CollerEvidence Quote
“these lipid nanoparticles, they lack what we call tropism... the only other place that we really have good ability to deliver to right now is the liver”
Created: 11/17/2026, 7:10:08 AM
Your notes
Loading notes...